Fig. 4From: Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanomaKaplan Meier curves showing progression-free (a) and disease-specific (b) survival, stratified by patterns of failure. PFS curves show 3 years while DSS curves show 5 years. * Denotes P < 0.05 by log-rank test. ** Denotes P < 0.01 by log-rank testBack to article page